Did anyone notice the market share report for the gene sequencing equipment and necessary reagents? It showed ABI as having upwards of 70% of the market. ABI also got positive feedback confirming they make the best equipment. And now it seems the stock is starting to grow along with the company news.I've owned this stock several years and lost money on it so far. I see about 20 positive things happening and still two things negative. Company sales and earnings do not grow even though market share is up. Apparently, the industry is at a stable size following its big growth in 1999 when they were racing to learn the sequence of human DNA.The other negative is that mutual funds already own nearly 90% of the stock.I spent a year learning the Investors Business Daily way of evaluating growth stocks. For what it's worth, this one looks primed to move if bottom line growth started to occur.CRC
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra